May 24, 2012
Bloomberg NewsThe U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Indianapolis-based Eli Lilly and
Co., Medtronic Inc. and other companies to fund reviews of new drugs and medical devices through 2017.
More
May 23, 2012
National Government Services Inc., which processes Medicare and Medicaid claims for the federal government, attributed the
job reductions to the loss of a government contract. The subsidiary will still have about 500 workers in Indianapolis.
More
May 23, 2012
J.K. WallThe merger of Kokomo’s Howard Regional Health System into Indianapolis-based Community Health Network received final
approval Tuesday night.
More
May 21, 2012
J.K. Wall
Since its acquisition last year by Florida-based AssuredPartners Inc., the Indiana operations of Neace Lukens has been looking
more aggressively to acquire smaller benefits brokers. In the past month, Neace Lukens has announced deals to buy Benefit
Concepts, a six-person benefits consultancy in Indianapolis, and Matrix Benefits and Consulting Group, a one-person benefits
shop in Fort Wayne. Eric Chelovitz, managing director of Neace Lukens’ 34-person Indianapolis office,
said he expects more consolidation in the industry.
More
May 21, 2012
J.K. WallIndiana University Health will refund the federal Medicare program $280,000 after an audit of almost 200 claims made by its
downtown hospitals found nearly 18 percent of them had been billed improperly.
More
May 21, 2012
Bloomberg NewsJohnson & Johnson and Bayer AG’s blood-thinner Xarelto should be approved to help prevent heart attacks and strokes
in patients with a common condition, a U.S. regulatory report recommended.
More
May 21, 2012
J.K. Wall
Most analysts agree with Eli Lilly and Co.’s prediction that, after tough years from 2012 to 2014, the drugmaker will
begin growing sales and profits again. But in a new report, BMO Capital Markets predicts Lilly will get stuck at a reduced
level of revenue and profit in 2014 and stay there for years.
More
May 17, 2012
Bloomberg NewsRaising good cholesterol, a goal pursued by Eli Lilly and Co. as the next milestone in cardiac care, may not cut heart-attack
risk, says a study that challenges the development of drugs that may someday generate billions of dollars in sales.
More
May 17, 2012
Bloomberg NewsEli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore,
Ireland and South Africa boost incentives.
More
May 17, 2012
Bloomberg NewsIndianapolis-based Eli Lilly and Co. and London-based AstraZeneca Plc aren't expected to have an easier time gaining more
of the market for blood thinners dominated by Bristol-Myers Squibb Co.’s Plavix after the drug loses U.S. patent protection
Thursday.
More
May 16, 2012
J.K. WallThe proposal, which sought twice-yearly reports on all the health insurer's donations used for political campaigns or lobbying,
was overwhelmingly voted down by WellPoint shareholders.
More
May 15, 2012
J.K. WallA mix of union groups, activist investors and single-payer advocates will call for increased disclosure from WellPoint, and
some investment funds will vote against WellPoint board members who they say have failed to exercise proper oversight of WellPoint’s
political spending.
More
May 14, 2012
J.K. WallIndiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies,
according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More
May 14, 2012
J.K. WallMuch of the nearly 45 minutes of arguments and questioning on May 10 involved the justices and the lawyers for both parties
trying unsuccessfully to apply various scenarios from the retail world of commerce to health care pricing.
More
May 12, 2012
Scott OlsonBut major Indianapolis-area hospitals still prefer personal referrals
More
May 12, 2012
Scott Tittle / Special to IBJBoom in elderly population and falling reimbursements expected to cause squeeze.
More
May 12, 2012
Myth prevents policymakers from attacking real problem of distributing funding.
More
May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More
May 12, 2012
J.K. WallProponents of such policies say they are the future of work—even as they acknowledge that it may take a generation for them
to be widely accepted. Some workers, however, are fearful.
More
May 11, 2012
Associated PressPurdue University's trustees approved plans Friday for a new campus medical clinic that administrators expect eventually
will cut the school's health care costs for employees and their families.
More
May 7, 2012
Associated PressA second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor
has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies. Eli Lilly is developing
a similar drug.
More
May 7, 2012
J.K. WallFor more than a year, Eli Lilly and Co. has been viewed by investors as a laggard stock with one, slim shot at producing a
huge jackpot: its experimental Alzheimer’s drug. But now company leaders are trying to direct investor attention toward
the drugmaker’s diabetes portfolio.
More
May 7, 2012
J.K. WallThe Indiana Supreme Court this week will consider whether hospital billing practices should be put on trial. The state’s
highest court will hear oral arguments Thursday in a case in which two uninsured patients have sued Indiana University Health
for charging them much higher prices than it would have charged insured patients.
More
May 7, 2012
J.K. WallDr. Malaz Boustani, the medical director of Wishard Health Services’ Healthy Aging Brain Center, thinks
pop-up alerts for physicians that are part of many electronic medical record and e-prescribing systems are ineffective and
need to be re-engineered.
More
May 5, 2012
J.K. WallWhen the same MRI at one facility costs $600 and at another costs $2,200, Dr. Robert Gregori would call that a business opportunity.
More
we love that we were right in our predictions for the outcome of Tony's boondoggle. We aren't negative, we are positive that the league that never has will continue to blow chunks and stink up the place
I was initially excited to learn that this wasn't rubber-stamped, but if all that is required is to add some shrubs and some "window dressing" over the first floor of the garage, then I'd call it a waste of everyone's time. It should be noted that the Hearing Examiner is a DMD employee who reports to the same administrator as the DMD staff planner who recommended approval of the garage and whose report said that the requirement for ground-floor retail had been "satisfied". Better luck with appealing the inevitable approval at the MDC, where the commissioners are appointed by the Mayor, City Council, and County Commissioners, thus, presumably not all obligated to facilitate the administration's plans.
Wheat Thins, when paired with chocolate ice cream!
About the same.
New airport, new Lucas Oil Stadium, expanded convention center, $30,000,000 Pacer gift, Stupid City Way Project, Broad Ripple Parking Garage $ Giveaway, Money blown on lethal bike lanes. The list is endless..
We have complete morons in City Government with grafter buddies sitting in the wings also stealing parking meter revenue. Go to www.adavceindiana.com and read about Chicago Parking Meter Corruption.
It's all theft of taxpayer resources and complete lack of financial stewardship and devoid of integrity.
I would just like for basic city services please.